<p>Invivyd, Inc.（纳斯达克代码：IVVD - 获取免费报告）的股票在周二下跌了 6%。该股最低交易价格为 2.23 美元，最后交易价格为 2.2550 美元。在交易过程中，共成交了 1,724,923 股，较平均交易量 7,911,324 股下降了 78%。该股此前收盘价为 2.40 美元。</p>
<h2>分析师评级变动</h2>
<p>最近，一些分析师对该股票发布了报告。HC Wainwright 将 Invivyd 的目标价格从 5.00 美元上调至 10.00 美元，并在 10 月 31 日的报告中给予该公司 “买入” 评级。Zacks Research 在 11 月 13 日的研究报告中将 Invivyd 的评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 10 月 31 日的报告中重申了对 Invivyd 股票的 “卖出（e+）” 评级。Cantor Fitzgerald 在 10 月 6 日的报告中开始覆盖 Invivyd，并设定了 “增持” 评级和 10.00 美元的目标价格。最后，D. Boral Capital 在周二的报告中重申了对 Invivyd 股票的 “持有” 评级。两位投资分析师给予该股票 “买入” 评级，两位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，Invivyd 的共识评级为 “持有”，共识目标价格为 7.33 美元。</p>
<p><strong>查看我们对 Invivyd 的最新分析</strong></p>
<h2>Invivyd 股票下跌 5.2%</h2>
<p>该公司的 50 日简单移动平均线为 1.71 美元，200 日简单移动平均线为 1.13 美元。该公司的市值为 5.3035 亿美元，市盈率为-4.84，贝塔值为 0.63。</p>
<p>Invivyd（纳斯达克代码：IVVD - 获取免费报告）最近于 11 月 6 日发布了季度财报。该公司报告季度每股收益（EPS）为-0.06 美元，低于分析师的共识预期-0.05 美元，差额为-0.01 美元。Invivyd 的净利润率为-119.63%，股本回报率为-92.97%。该季度的收入为 1313 万美元，而共识预期为 1200 万美元。整体来看，分析师预计 Invivyd, Inc.在当前财政年度的每股收益为-1.64 美元。</p>
<h2>Invivyd 的内部活动</h2>
<p>在其他消息中，董事 Kevin F. Mclaughlin 于 11 月 19 日星期三收购了 50,000 股该公司的股票。该股票的平均购买价格为每股 2.50 美元，总价值为 125,000.00 美元。收购完成后，该董事直接持有 50,000 股公司的股票，价值约为 125,000 美元。此次交易使其持股增加了∞。该购买在向证券交易委员会的法律文件中披露，相关文件可通过 SEC 网站获取。25.40% 的股票由公司内部人士持有。</p>
<h2>对 Invivyd 的对冲基金看法</h2>
<p>几家大型投资者最近对 IVVD 的持仓进行了调整。Catalyst Funds Management Pty Ltd 在第二季度购买了 Invivyd 的新股份，价值约 27,000 美元。Vanguard Personalized Indexing Management LLC 在第二季度将其在 Invivyd 的持仓提高了 238.6%。Vanguard Personalized Indexing Management LLC 现在拥有 39,941 股该公司的股票，价值 29,000 美元，此前在该期间又购买了 28,146 股。美国银行（Bank of America Corp DE）在第三季度将其在 Invivyd 的持仓增加了 330.5%。美国银行（Bank of America Corp DE）现在拥有 49,252 股该公司的股票，价值 54,000 美元，此前在上个季度又收购了 37,811 股。Nuveen LLC 在第一季度购买了 Invivyd 的新股份，价值约 65,000 美元。最后，XTX Topco Ltd 在第一季度购买了 Invivyd 的新股份，价值约 66,000 美元。目前，70.36% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Invivyd 公司简介</h2>
<p>（获取免费报告）</p>
<p>Invivyd, Inc.是一家商业阶段的生物制药公司，专注于在美国发现、开发和商业化针对传染病的抗体解决方案。该公司开发了 INVYMAB，这是一个将病毒监测和预测建模与先进抗体工程相结合的平台。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Invivyd 更好</li>
<li>什么是国债？</li>
<li>错过了人工智能的繁荣？这两只被压制的股票可能是你的第二次机会</li>
<li>在经济衰退中与这些股息之王共度难关</li>
<li>六旗的新领导者：过山车结束了吗？</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>百度可能成为全球人工智能的黑马的三个理由</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Invivyd 吗？</h2>
<p>在考虑 Invivyd 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Invivyd 并不在名单上。</p>
<p>虽然 Invivyd 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

IVVD

<p>Invivyd, Inc.（纳斯达克代码：IVVD）股价下跌 6%，至 2.2550 美元，交易量较平均水平下降 78%。分析师的评级意见不一：HC Wainwright 将目标价上调至 10 美元，并给予 “买入” 评级，而 Weiss Ratings 则维持 “卖出” 评级。该股票的共识评级为 “持有”，目标价为 7.33 美元。最近的内部交易活动包括一名董事购买了 50,000 股。对冲基金和机构投资者持有该股票的 70.36%</p>

<p>Shares of Invivyd, Inc. (NASDAQ:IVVD - Get Free Report) fell 6% on Tuesday . The stock traded as low as $2.23 and last traded at $2.2550. 1,724,923 shares traded hands during trading, a decline of 78% from the average session volume of 7,911,324 shares. The stock had previously closed at $2.40.</p>
<div class="lb-trans"><p>Invivyd, Inc.（纳斯达克代码：IVVD - 获取免费报告）的股票在周二下跌了 6%。该股最低交易价格为 2.23 美元，最后交易价格为 2.2550 美元。在交易过程中，共成交了 1,724,923 股，较平均交易量 7,911,324 股下降了 78%。该股此前收盘价为 2.40 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of analysts have recently issued reports on the stock. HC Wainwright raised their price objective on Invivyd from $5.00 to $10.00 and gave the company a &#34;buy&#34; rating in a report on Friday, October 31st. Zacks Research upgraded Invivyd from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, November 13th. Weiss Ratings reaffirmed a &#34;sell (e+)&#34; rating on shares of Invivyd in a report on Friday, October 31st. Cantor Fitzgerald started coverage on Invivyd in a report on Monday, October 6th. They set an &#34;overweight&#34; rating and a $10.00 price target on the stock. Finally, D. Boral Capital reaffirmed a &#34;hold&#34; rating on shares of Invivyd in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Invivyd has a consensus rating of &#34;Hold&#34; and a consensus target price of $7.33.</p>
<div class="lb-trans"><p>最近，一些分析师对该股票发布了报告。HC Wainwright 将 Invivyd 的目标价格从 5.00 美元上调至 10.00 美元，并在 10 月 31 日的报告中给予该公司 “买入” 评级。Zacks Research 在 11 月 13 日的研究报告中将 Invivyd 的评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 10 月 31 日的报告中重申了对 Invivyd 股票的 “卖出（e+）” 评级。Cantor Fitzgerald 在 10 月 6 日的报告中开始覆盖 Invivyd，并设定了 “增持” 评级和 10.00 美元的目标价格。最后，D. Boral Capital 在周二的报告中重申了对 Invivyd 股票的 “持有” 评级。两位投资分析师给予该股票 “买入” 评级，两位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，Invivyd 的共识评级为 “持有”，共识目标价格为 7.33 美元。</p>
</div><p><strong>View Our Latest Analysis on Invivyd</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Invivyd 的最新分析</strong></p>
</div><h2>Invivyd Stock Down 5.2%</h2>
<div class="lb-trans"><h2>Invivyd 股票下跌 5.2%</h2>
</div><p>The firm's 50-day simple moving average is $1.71 and its 200-day simple moving average is $1.13. The firm has a market capitalization of $530.35 million, a P/E ratio of -4.84 and a beta of 0.63.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 1.71 美元，200 日简单移动平均线为 1.13 美元。该公司的市值为 5.3035 亿美元，市盈率为-4.84，贝塔值为 0.63。</p>
</div><p>Invivyd (NASDAQ:IVVD - Get Free Report) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.01). Invivyd had a negative net margin of 119.63% and a negative return on equity of 92.97%. The business had revenue of $13.13 million for the quarter, compared to the consensus estimate of $12.00 million. As a group, analysts expect that Invivyd, Inc. will post -1.64 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Invivyd（纳斯达克代码：IVVD - 获取免费报告）最近于 11 月 6 日发布了季度财报。该公司报告季度每股收益（EPS）为-0.06 美元，低于分析师的共识预期-0.05 美元，差额为-0.01 美元。Invivyd 的净利润率为-119.63%，股本回报率为-92.97%。该季度的收入为 1313 万美元，而共识预期为 1200 万美元。整体来看，分析师预计 Invivyd, Inc.在当前财政年度的每股收益为-1.64 美元。</p>
</div><h2>Insider Activity at Invivyd</h2>
<div class="lb-trans"><h2>Invivyd 的内部活动</h2>
</div><p>In other news, Director Kevin F. Mclaughlin acquired 50,000 shares of the business's stock in a transaction that occurred on Wednesday, November 19th. The stock was bought at an average price of $2.50 per share, with a total value of $125,000.00. Following the completion of the acquisition, the director directly owned 50,000 shares of the company's stock, valued at approximately $125,000. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through the SEC website. 25.40% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，董事 Kevin F. Mclaughlin 于 11 月 19 日星期三收购了 50,000 股该公司的股票。该股票的平均购买价格为每股 2.50 美元，总价值为 125,000.00 美元。收购完成后，该董事直接持有 50,000 股公司的股票，价值约为 125,000 美元。此次交易使其持股增加了∞。该购买在向证券交易委员会的法律文件中披露，相关文件可通过 SEC 网站获取。25.40% 的股票由公司内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Invivyd</h2>
<div class="lb-trans"><h2>对 Invivyd 的对冲基金看法</h2>
</div><p>Several large investors have recently made changes to their positions in IVVD. Catalyst Funds Management Pty Ltd purchased a new stake in shares of Invivyd during the 2nd quarter worth approximately $27,000. Vanguard Personalized Indexing Management LLC raised its position in Invivyd by 238.6% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 39,941 shares of the company's stock worth $29,000 after purchasing an additional 28,146 shares during the period. Bank of America Corp DE grew its position in Invivyd by 330.5% in the 3rd quarter. Bank of America Corp DE now owns 49,252 shares of the company's stock valued at $54,000 after acquiring an additional 37,811 shares during the last quarter. Nuveen LLC bought a new stake in Invivyd during the 1st quarter valued at about $65,000. Finally, XTX Topco Ltd purchased a new stake in shares of Invivyd in the first quarter valued at approximately $66,000. 70.36% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家大型投资者最近对 IVVD 的持仓进行了调整。Catalyst Funds Management Pty Ltd 在第二季度购买了 Invivyd 的新股份，价值约 27,000 美元。Vanguard Personalized Indexing Management LLC 在第二季度将其在 Invivyd 的持仓提高了 238.6%。Vanguard Personalized Indexing Management LLC 现在拥有 39,941 股该公司的股票，价值 29,000 美元，此前在该期间又购买了 28,146 股。美国银行（Bank of America Corp DE）在第三季度将其在 Invivyd 的持仓增加了 330.5%。美国银行（Bank of America Corp DE）现在拥有 49,252 股该公司的股票，价值 54,000 美元，此前在上个季度又收购了 37,811 股。Nuveen LLC 在第一季度购买了 Invivyd 的新股份，价值约 65,000 美元。最后，XTX Topco Ltd 在第一季度购买了 Invivyd 的新股份，价值约 66,000 美元。目前，70.36% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Invivyd Company Profile</h2>
<div class="lb-trans"><h2>Invivyd 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.</p>
<div class="lb-trans"><p>Invivyd, Inc.是一家商业阶段的生物制药公司，专注于在美国发现、开发和商业化针对传染病的抗体解决方案。该公司开发了 INVYMAB，这是一个将病毒监测和预测建模与先进抗体工程相结合的平台。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Invivyd</li>
<li>What Are Treasury Bonds?</li>
<li>Missed the AI Boom? These 2 Crushed Stocks Could Be Your Second Chance</li>
<li>Ride Out The Recession With These Dividend Kings</li>
<li>A New Leader at Six Flags: Is the Roller Coaster Over?</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>3 Reasons Baidu Could Be the Dark Horse of Global AI</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Invivyd 更好</li>
<li>什么是国债？</li>
<li>错过了人工智能的繁荣？这两只被压制的股票可能是你的第二次机会</li>
<li>在经济衰退中与这些股息之王共度难关</li>
<li>六旗的新领导者：过山车结束了吗？</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>百度可能成为全球人工智能的黑马的三个理由</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Invivyd Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Invivyd 吗？</h2>
</div><p>Before you consider Invivyd, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Invivyd 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invivyd wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Invivyd 并不在名单上。</p>
</div><p>While Invivyd currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Invivyd 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Invivyd（NASDAQ:IVVD）股价下跌 6% - 以下是原因